RxDoctor Payments DataLook up a doctor →

Shaun Hanson, MD

Hematology · Saint Louis, MONPI 1831464130

Payments from drug & device makers

$15,392in general payments, 2019–2025

Across 746 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$909
  • Novartis$835
  • Johnson & Johnson$791
  • E.r. Squibb & Sons, L.L.C.$772
  • AbbVie$747
  • AstraZeneca$730
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck48$909
Novartis41$835
Johnson & Johnson(2 entities)40$791
E.r. Squibb & Sons, L.L.C.37$772
AbbVie25$747
AstraZeneca(2 entities)37$730
Pfizer36$677
Incyte Corporation27$439
Seagen Inc.24$436
Genentech USA, Inc.18$410
Sanofi19$385
Eisai Inc.18$373
Regeneron Healthcare Solutions, Inc.15$364
Daiichi Sankyo Inc.15$348
Amgen18$347
Gilead(2 entities)19$346
Lilly USA, LLC15$288
GSK14$288
Bristol Myers Squibb14$273
Bayer17$268
Exelixis Inc.12$267
EMD Serono, Inc.13$264
Takeda Pharmaceuticals U.S.A., Inc.11$251
Beigene USA, Inc.7$248
Pharmacyclics LLC, An Abbvie Company11$220
Taiho Oncology, Inc.11$189
Boehringer Ingelheim9$182
Blueprint Medicines Corporation7$171
Karyopharm Therapeutics Inc.8$170
Genentech, Inc.3$168
Astellas Pharma US Inc10$167
Aimmune Therapeutics, Inc.3$155
Servier Pharmaceuticals LLC7$133
Pharmaessentia USA Corporation7$129
Kyowa Kirin, Inc.7$128
Jazz Pharmaceuticals Inc.5$126
Insmed, Inc.1$125
Viiv Healthcare Company1$125
Puma Biotechnology, Inc.6$113
Tersera Therapeutics LLC4$109
Rigel Pharmaceuticals, Inc.7$103
Array Biopharma Inc7$100
ADC Therapeutics America, Inc.4$80
Genmab U.S., Inc.4$77
Recordati_rare_diseases_inc.3$75
Emmaus Medical, Inc.3$70
Tempus AI, Inc4$70
Springworks Therapeutics, Inc.3$68
Stemline Therapeutics Inc.3$68
Clovis Oncology, Inc.5$67
Mirati Therapeutics, Inc.3$66
Morphosys, US Inc.4$63
Sobi, Inc3$63
Coherus Oncology, Inc.4$61
Sun Pharmaceutical Industries Inc.4$60
Myriad Genetic Laboratories, Inc.3$57
Myovant Sciences Inc.3$57
Epizyme, Inc.4$55
Ipsen Biopharmaceuticals, Inc2$53
Global Blood Therapeutics, Inc.3$49

How this compares

$15,392 in reported general payments places this provider in the 55th percentile of 27 hematology providers in Missouri.

See all hematology providers in Missouri →

Medicare billing

Part B allowed, 2024
$72,474
Medicare patients
285
Services billed
680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →